Potential of trichloroacetic acid (TCA) for cervical precancerous lesions treatment in Indonesia
Downloads
HIGHLIGHTS
1. One of the most prevalent disease in females worldwide is cervical cancer.
2. Simple and safe modality with high efficacy to treat cervical precancerous lesions before being progressed to cancer is necessary.
3. Trichloroacetic acid (TCA) has those advantages, so it will become an effective treatment for cervical precancerous lesions in the future.
ABSTRACT
Cervical cancer becomes one of the most prevalent disease in female worldwide. Human papillomavirus (HPV) is main etiology of cervical cancer, thus this disease is preventable. Before progressed into invasive cervical cancer, cervical precancerous lesions developed and classified into 3 stages: CIN1 (LSIL), CIN2, and CIN3 (CIN2+ also referred as HSIL). World Health Organization (WHO) arranged ‘screen-and-treat' programme to treat cervical precancerous lesions immediately before it progressed to cancer. However, a simple and safe modality with high efficacy is necessary to accommodate this strategy. Trichloroacetic acid (TCA) has those advantages and some research suggested high efficacy to treat cervical precancerous lesions with simple, safe, and cost-effective. TCA has potential to become effective treatment for cervical precancerous lesions in the future.
International Agency for Research on Cancer. Cervical cancer estimated indidence, mortality and prevelence worldwide in 2012. Ministry of Health, Republic of Indonesia. 2017.
Andrijono. Sinopsis kanker ginekologi [Synopsis of gynecological cancer]. 4th ed. Jakarta: Balai Penerbit FK UI; 2013. p. 59–129.
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3): 209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Centers for Disease Control and Prevention. Basic information about HPV and cancer [Internet]. CDC. 2020 [cited 2021 Sep 27]. Available from: https://www.cdc.gov/cancer/hpv/basic_info/index.htm
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020 – 2030. Vol. 2, United Nations General Assembly. 2021. Available from: http://apps.who.int/bookorders.
World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization; 2013.
Darwish AM, Zahran KM. Trichloroacetic acid application versus spray monopolar diathermy for treating benign cervical lesions: a randomized controlled clinical trial. J Low Genit Tract Dis. 2013(3):248-54. doi: 10.1097/LGT.0b013e31827 527e3. PMID: 23733165.
Fader AN. Surgery in cervical cancer. N Engl J Med. 2018;379(20):1955-7. doi: 10.1056/NEJMe 1814034. Epub 2018 Oct 31. PMID: 30379600; PMCID: PMC6989030.
Wakeham K, Kavanagh K. The burden of HPV-associated anogenital cancers. Curr Oncol Rep. 2014;16(9):402. doi: 10.1007/s11912-014-0402-4. PMID: 25118645.
Ratnasari DT. Kondiloma akuminata. J Ilm Kedokt Wijaya Kusuma. 2018;5(2). doi: 10.30742/jikw. v5i2.336
Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161-e169. doi: 10.1016/S2214-109X(20)30459-9. Epub 2020 Nov 16. Erratum in: Lancet Glob Health. 2021 Feb;9(2):e119. PMID: 33212031; PMCID: PMC7815633.
Geisler S, Speiser S, Speiser L, et al. Short-term efficacy of trichloroacetic acid in the treatment of cervical intraepithelial neoplasia. Obstet Gynecol. 2016;127(2):353-9. doi: 10.1097/AOG.0000000000 001244. PMID: 26942365.
Basu P, Taghavi K, Hu S-Y, et al. Management of cervical premalignant lesions. Curr Probl Cancer 2018;42(2):129–36. doi: 10.1016/j.currproblcancer. 2018.01.010
Liu Y, Sigel K, Gaisa MM. Human papillomavirus genotypes predict progression of anal low-grade squamous intraepithelial lesions. J Infect Dis. 2018;218(11):1746-52. doi: 10.1093/infdis/ jiy463. PMID: 30053247; PMCID: PMC6195660.
Kombe Kombe AJ, Li B, Zahid A, et al. Epidemio-logy and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2021 ;8:552028. doi: 10.3389/fpubh.2020.552028. PMID: 3355 3082; PMCID: PMC7855977.
Skinner SR, Wheeler CM, Romanowski B, et al. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer. 2016;138(10):2428-38. doi: 10.1002/ijc. 29971. PMID: 26685704; PMCID: PMC4787275.
Mirabello L, Clarke MA, Nelson CW, et al. The intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcino-genesis. Viruses. 2018 Feb 13;10(2):80. doi: 10.3390/v10020080. PMID: 29438321; PMCID: PMC5850387.
Bowden SJ, Kalliala I, Veroniki AA, et al. The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis. EBioMedicine. 2019;50:246-259. doi: 10.1016/j.ebiom.2019.10. 053. Epub 2019 Nov 12. PMID: 31732479; PMC ID: PMC6921230.
Koeneman MM, van Lint FHM, van Kuijk SMJ, et al. A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters. Hum Pathol. 2017;59:62-69. doi: 10.1016/j.humpath.2016.09. 012. Epub 2016 Sep 30. PMID: 27697590.
Rositch AF, Burke AE, Viscidi RP, et al. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res. 2012;72(23):6183-90. doi: 10.1158/ 0008-5472.CAN-12-2635. Epub 2012 Sep 27. PMID: 23019223; PMCID: PMC3513486.
Gravitt PE, Rositch AF, et al. A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. J Infect Dis. 2013;207(2):272–80. doi: 10.1093/infdis/jis660
Demarco M, Lorey TS, Fetterman B, et al. Risks of CIN 2+, CIN 3+, and cancer by cytology and human papillomavirus status: The foundation of risk-based cervical screening guidelines. J Low Genit Tract Dis. 2017;21(4):261-267. doi: 10.1097/LGT.0000000000000343. PMID: 28953 116; PMCID: PMC5625966.
Yanofsky VR, Patel RV, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012;5(6):25-36. PMID: 22768354; PMCID: PMC3390234.
Fein LA, Marbin SJ. Condylomata acuminata of the neovagina in a transgender woman treated with trichloroacetic acid. Int J STD AIDS. 20201;31(10) :1011–3. doi: 10.1177/0956462420937161
Copyright (c) 2022 Majalah Obstetri & Ginekologi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
